Abstract: In an example, an apparatus is described that includes an implantable housing, a heart signal sensing circuit configured to sense intrinsic electrical heart signals, a ventricular tachyarrhythmia (VT) detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals, a processor configured to control delivery of an anti-tachyarrhythmia pacing (ATP) therapy based on the detected VT, and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock.

Abstract: Medical devices and methods for making and using medical devices are disclosed. An example medical device may include a medical device for measuring blood pressure. The medical device may include an elongated shaft having a proximal region and a distal region. An optical fiber may extend along the proximal region. An optical pressure sensor may be coupled to the optical fiber. The optical pressure sensor may be disposed along the distal region. A centering member may be coupled to the optical fiber and positioned adjacent to the optical pressure sensor.

Abstract: Medical devices and methods for making and using medical devices are disclosed. An example method may include a method for calculating fractional flow reserve including providing a pressure sensing guidewire, advancing the pressure sensing guidewire through a blood vessel to a first position distal of an intravascular occlusion, determining a distal pressure within the body lumen with the pressure sensing guidewire, proximally shifting the pressure sensing guidewire to a second position proximal of the occlusion, determining a proximal pressure within the body lumen with the pressure sensing guidewire, measuring an aortic pressure, and calculating a pressure drift. The pressure drift may be the difference between the aortic pressure and the proximal pressure. The method may also include calculating a drift-compensated fractional flow reserve. The drift-compensated fraction flow reserve may correspond to (the distal pressure+the pressure drift) divided by the aortic pressure.

Abstract: Arrangements are described for generating electrode stimulation signals for an implanted electrode array having multiple stimulation contacts. An audio input preprocessor receives an input audio signal and generates band pass signals that represent associated bands of audio frequencies. A band pass signal analyzer analyzes each band pass signal to detect when one of the band pass signal components reaches a defined transition event state. A stimulation signal generator generates a set of electrode stimulation signals for the stimulation contacts from the band pass signals such that the electrode stimulation signals to a given stimulation contact: i. use a transition event stimulation pattern whenever a transition event is detected in a band pass signal associated with the given stimulation contact, and ii. use a different non-transition stimulation pattern after the transition event stimulation pattern until a next subsequent transition event is detected.

Abstract: A system, method and device are described for detecting a heart rate. A sensing unit can have a skin-facing surface that is removably securable to a user's skin surface and include at least one sensor positioned to acquire a bio-signal from the skin surface. A controller can be configured to capture a bio-signal stream using the at least one sensor and generate a preprocessed bio-signal stream by band-pass filtering the captured bio-signal stream with a predetermined passband. The controller can also be configured to determine, in a moving window, heartbeat signal portions when the preprocessed bio-signal stream has heartbeat impulse characteristics and determine the time between adjacent heartbeat signal portions to compute the heart rate.

Abstract: Transcranial magnetic stimulation (TMS) is a remarkable tool for probing the brain. However, it is still unclear why specific regions in the cortex are excitable by TMS while others are not. This invention provides methods and tools for the design of efficient magnetic stimulators. Such stimulators can excite neuronal networks that were not sensitive to stimulation until now. Stimulation can be carried out both in-vitro and in-vivo. Novel systems and techniques of this invention will enable both treatment and diagnostics by stimulating regions of the brain or neuronal assemblies that were previously unaffected by TMS.

Abstract: An example of a system may include electrodes on at least one lead configured to be operationally positioned for use in modulating neural tissue where the neural tissue including dorsal horn tissue or nerve root tissue, a neural modulation generator, and a controller. The neural modulation generator may be configured to use at least some electrodes to generate a modulation field. The neural modulation generator maybe configured to use a programmed modulation parameter set to promote uniformity of the modulation field in the dorsal horn tissue. The controller may be configured to control the neural modulation generator to generate the modulation field in pulse trains of at least two pulses.

Abstract: Apparatus, comprising (1) a first controller comprising at least one first-controller antenna configured to transmit a first wireless power signal having a first signal power; and a first-controller control unit configured to use battery power to drive the first-controller antenna; (2) a second controller, comprising at least one second-controller antenna, configured to transmit a second wireless power signal having a second signal power; and a second-controller control unit, configured to use mains electricity power to drive the second-controller antenna; and (3) an implant, comprising one or more electrodes; at least one implant antenna configured to receive 1-10 percent of the first signal power, and to receive 0.01-1 percent of the second signal power; and circuitry configured to drive the one or more electrodes responsively to the received 1-10 percent of the first signal power, or the received 0.01-1 percent of the second signal power.

Abstract: The present application relates to a new stimulation design which can be utilized to treat neurological conditions. The stimulation system produces a burst mode stimulation which alters the neuronal activity of the predetermined site, thereby treating the neurological condition or disorder. The burst stimulus comprises a plurality of groups of spike pulses having a maximum inter-spike interval of 100 milliseconds. The burst stimulus is separated by a substantially quiescent period of time between the plurality of groups of spike pulses. This inter-group interval may comprise a minimum of 5 seconds.

Abstract: The disclosure pertains to an intravascular catheter for nerve modulation, comprising an elongate member having a proximal end and a distal end, a balloon having a lumen and a balloon wall, the balloon wall comprising RF permeable sections and non-electrically conductive sections, an electrode disposed within the balloon and extending distally to the furthest distal RF permeable section. The RF permeable sections may comprise a plurality of RF permeable windows, each window having a greater circumferential dimension than an axial dimension. The intravascular system is suited for modulation of renal nerves.

Abstract: Systems configured to apply pressure to a foot and electrically stimulate muscles to contract in order to increase circulation and facilitate removal of metabolic waste, and related methods, are disclosed. One exemplary embodiment comprises an actuator that repeatedly compresses the bottom of a foot and an electrical muscle stimulator that repeatedly sends electrical pulses to a muscle to facilitate a muscle contraction. The system may also include a compression garment, such as a compression sock to be worn while undergoing both the repeated compression cycles and the repeated electrical pulses. The system may also include an item of footwear, wherein the actuator portion is partially or completely contained within the item of footwear. Additionally and/or alternatively, the electrical muscle stimulator may be partially or completely contained within the item of footwear.

Abstract: The present disclosure relates to devices, systems and methods for evaluating the success of a treatment applied to tissue in a patient, such as a radio frequency ablative treatment used to neuromodulate nerves associated with the renal artery. A system monitors parameters or values generated during the course of a treatment. Feedback provided to an operator is based on the monitored values and relates to an assessment of the likelihood that a completed treatment was technically successful. In other embodiments, parameters or values generated during the course of an incomplete treatment (such as due to high temperature or high impedance conditions) may be evaluated to provide additional instructions or feedback to an operator.

Abstract: In one general aspect, an implant includes a cuff defining an opening configured to receive a cannula coupled to a heart pump. The implant includes a coupling mechanism having a first position and a second position, the cuff being uncoupled from the cannula in the first position and the coupling mechanism coupling the cuff to the cannula in the second position. The implant includes a locking mechanism configured to secure the coupling mechanism in the second position, and the locking mechanism is configured to be moved to a locked position after the coupling mechanism is in the second position.

Abstract: In summary the invention utilizes a patient's interaction with a user interface 120 of a controllable lighting system 100. The user interface enables light characteristics of the lighting system 100 to be adjusted such as the light color emitted from a light source 110 of the lighting system 100. A monitor 130 is provided for monitoring how the patient interacts with the user interface 120, e.g. by monitoring how frequent the patient interacts with the user interface, the monitored number of interactions may be processed by a processor 140 to determine a value of the coping style which indicates how active or passive the patient is.

Abstract: A forceps includes a housing defining a window and having an outer shaft extending therefrom. An end effector assembly disposed at a distal end of the outer shaft includes first and second jaw members including distal portions and proximal portions and movable between spaced-apart and approximated positions. An inner shaft is slidably disposed within the outer shaft such that, when the jaw members are disposed in the spaced-apart position, the inner shaft is disposed in a distal position. When the jaw members are moved to the approximated position, the proximal portions urge the inner shaft to a proximal position. An indicator member coupled to the inner shaft includes first and second indicators. The first indicator is visible through the window when the inner shaft is disposed in the distal position. The second indicator is visible through the window when the inner shaft is disposed in the proximal position.

Abstract: A rescue cell apparatus used for cardiac defibrillation of a patient, the apparatus comprising: a hand held device for sending and receiving communication signals and configured to be used as a remote control to administer a defibrillation pulse to the patient for cardiac defibrillation; a defibrillator unit having a sensor electronic pad positionable on the patient, the sensor electronic pad adapted to deliver the defibrillation pulse; and a second electronic pad, connectable by an electrical wire to the defibrillator unit, the second electronic pad positionable on the patient and adapted to detect ECG signals and to deliver the defibrillation pulse to the patient; and an image recognition module configured in the handheld device, and adapted to verify positioning of the sensor electronic pad and the second electronic pad on the patient before defibrillation.

Abstract: An example of a system may include an electrode arrangement, a neural modulation generator configured to use electrodes in the electrode arrangement to generate a modulation field, a communication module configured to receive commands, a memory configured to store modulation field parameter data, and a controller configured to control the neural modulation generator to generate the modulation field. The controller may be configured to implement a trolling routine to troll the modulation field through neural tissue positions, and implement a marking routine multiple times as the modulation field is trolled through the neural tissue positions to identify when the modulation field provides patient-perceived modulation.

Abstract: Various embodiments are described herein that generally relate to a low-level laser therapy (LLLT) device to aid in at least one of the prevention and treatment of hair loss, rejuvenation of hair, and stimulation of hair regrowth for a certain percentage of users. In at least one embodiment, a plurality of emitters and bristles may be arranged in rows on a concave active surface of a housing for facing a treatment surface of the user. In some embodiments, the device is a laser therapy helmet device, wherein a portion of the device rotates relative to the treatment surface during use. In at least some embodiments, the device may further comprise a plurality of modes of operation for delivering different amounts of energy to the treatment surface.

Abstract: A hospitalization management system including a heart failure analyzer that receives diagnostic data including at least sensor data representative of one or more physiological signals sensed from a hospitalized patient using one or more sensors and assesses risk of rehospitalization for the patient using the diagnostic data. The outcome of the risk assessment is used during and following the patient's hospitalization for reducing the risk of rehospitalization.

Abstract: Methods, devices and systems for separating an implanted object, such as a lead attached to a cardiac conduction device, from formed tissue within a blood vessel are provided. The methods, devices and systems for separating a lead from the tissue relate to dilating the tissue surrounding the lead from underneath the tissue and/or between the lead and the tissue.